Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Standard-Essential Patent Licensing Comes To Medtech

    Connected technology products are a part of daily life. Connectivity standards – such as 5G and Wi-Fi – provide a common language that allows products from different manufacturers to communicate with each other.
    United StatesIntellectual Property
    WilmerHale
    WilmerHale
  • Article

    The Future Of Prenatal Molecular Diagnostics: Impact Of The Changing Patent Landscape

    Recent developments in US patent law will provide both challenges and opportunities for creating effective intellectual property and commercialization strategies for prenatal molecular diagnostic methods and may ultimately influence provider and patient access to certain tests.
    United StatesIntellectual Property
    Fox Rothschild LLP
Fox Rothschild LLP
  • Article

    Trends In Inter Partes Review Of Life Sciences Patents

    A statistical analysis of inter partes review proceedings before the Patent Trial and Appeal Board shows that the PTAB is not a ‘‘death squad'' for patents.
    United StatesIntellectual Property
    WilmerHale
    WilmerHale
  • Article

    USPTO Announces Cancer Moonshot Expedited Examination Pilot Program

    The USPTO has published a Federal Register Notice announcing a new program: the Cancer Moonshot Expedited Examination Pilot Program.
    United StatesIntellectual Property
    Oblon
    Oblon
  • Article

    International Trade Commission Institutes Investigation Of Alvotech's Adalimumab Biosimilar

    As noted in our December 21, 2021 post, Complainants AbbVie Inc., AbbVie Biotechnology Ltd. and AbbVie Operations Singapore Pte. Ltd. filed a complaint at the International Trade Commission against Respondents Alvotech hf..
    United StatesInternational Law
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    OFAC Issues New FAQ On Certain Iranian Sanctions

    In a new FAQ, OFAC addressed the treatment under Executive Order 13902 ("Imposing Sanctions With Respect to Additional Sectors of Iran") of Iranian manufacturers who provide humanitarian goods.
    United StatesInternational Law
    Hogan Lovells Cadwalader
    Hogan Lovells Cadwalader
  • Article

    ‘Entrepreneur Spotlight' Showcases PA Biotech Companies To Potential Investors

    The Baruch S. Blumberg Institute recently hosted the awards ceremony "Entrepreneur Spotlight" at the Pennsylvania Biotechnology Center of Bucks County.
    United StatesLaw Practice Management
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    Podcast Series: Last Month At The Federal Circuit - August 2018

    In this podcast, Finnegan partner Mike Jakes discusses recent developments in Saint Regis Mohawk Tribe v. Mylan Pharmaceuticals and NantKwest v. Iancu.
    United StatesLitigation, Mediation & Arbitration
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    SDNY Rejects Standing Under "Increased Risk" Theory Where Data Not Targeted Or Stolen

    Defendants in breach cases in federal court should always test standing as a potential way to terminate the case early.
    United StatesPrivacy
    Shook, Hardy & Bacon LLP
    Shook, Hardy & Bacon LLP
  • Video

    Propsci Perspectives: Breakthrough Properties (Video)

    The Goodwin Propsci team has partnered with several well-known companies for a short video series that explores what's happening in the real estate life sciences industry.
    United StatesReal Estate and Construction
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Propsci Perspectives: JLL

    The Goodwin Propsci team has partnered with several well-known companies for a short video series that explores what's happening in the real estate life sciences industry.
    United StatesReal Estate and Construction
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    3 Ways To Manage The Cyber Risk Posed By Connected Medical Devices

    Connected medical technology is rapidly transforming patient treatment.
    United StatesTechnology
    Hogan Lovells
    Hogan Lovells
  • Article

    Alvotech And STADA Obtain Approval In Europe For Ustekinumab Biosimilar, UZPRUVO

    On January 10, Alvotech announced that the European Commission (EC) issued a marketing authorization to its European commercialization partner, STADA, for UZPRUVO (AVT04), a biosimilar referencing STELARA (ustekinumab).
    European UnionFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Commission To Provide Legal Analysis On Applicability Of GMO Legislation To New Plant Breeding Techniques

    The International Federation of Organic Agriculture Movements EU has published a position paper urging the EC to classify such techniques as falling within the scope of the GMO legislation.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    EU Launches Four Clinical Trial Public Consultations

    On June 1, 2016, the European Commission launched four public consultations in the field of clinical trials.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Biogen's TOFIDENCE (Tocilizumab) Approved In The EU

    This week, Biogen announced that the European Commission has approved TOFIDENCE, a tocilizumab biosimilar referencing Roche's ROACTEMRA. TOFIDENCE was approved by the FDA in September 2023.
    GlobalFamily and Matrimonial
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    STADA And Xbrane Announce Approval Of Ranibizumab Biosimilar In Europe

    On November 11, 2022, STADA Arzneimittel AG ("STADA") and Xbrane Biopharma AB ("Xbrane") announced that the European Commission has granted a marketing authorization for XIMLUCI (ranibizumab), a biosimilar to Genentech's LUCENTIS.
    GlobalFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Video

    Fallen Angel Reverse Mergers – Matthew Gardella, Member, Corporate & Securities Practice (Video)

    Matthew Gardella explains why "fallen angel" reverse mergers have become an attractive alternative to the traditional IPO for privately held life sciences companies looking to go public.
    United StatesCorporate/Commercial Law
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Article

    Technology And Life Sciences IPO Survey – 2014, Full Year

    This report analyzes key aspects of initial public offerings (IPOs) for 140 technology and life sciences companies that went public in 2014.
    United StatesCorporate/Commercial Law
    Fenwick
    Fenwick
  • Article

    Foley Hoag Referenced By Hospice News

    Hospice news referenced a recent report by Foley Hoag about False Claims Act enforcement regarding the federal government resolving roughly 350 FCA cases during 2022...
    United StatesCriminal Law
    Foley Hoag LLP
    Foley Hoag LLP
  • Showing 601–620 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics